NAMI receives majority of donations from pharmceutical companies

October 27, 2009

A majority of donations made to the National Alliance on Mental Illness, a big advocacy group, have come from drug makers in recent years, according to Congressional investigators. The disclosure comes after protracted criticism of NAMI for coordinating lobbying efforts with drug makers and pushing legislation that also benefits the pharma industry, The New York Times reports.

Here’s a link to the Times’ article by Gardiner Harris